TITLE 77: PUBLIC HEALTH
CHAPTER X: DEPARTMENT OF HUMAN SERVICES
SUBCHAPTER f: CANNABIS ACTIVITIES
PART 2085 RESEARCH
SECTION 2085.10 DEFINITIONS
Section 2085.10 Definitions
As used in this Part, unless the context otherwise requires:
"Delta-9-THC" means delta-9-tetrahydrocannabinol capsules issued by the National Cancer Institute for the treatment of cancer chemotherapy patients.
"DEA" means the Drug Enforcement Administration of the United State Department of Justice or its successor agency.
"Guidelines" means the "Group C Guidelines for the Use of Delta-9-tetrahydrocannabinol NSC 134454 for Nausea and Vomiting Induced by Antineoplastic Chemotherapy", Protocol 180-12, September, 1080, issued by the National Cancer Institute".
"Mechanism" means the "Mechanism of Drug Distribution for Delta-9-Tetrahydrocannabinol (NSC-134454)" issued by the National Cancer Institute.
"NCI" means the National Cancer Institute or its successor agency.
"Research Order Forms" means the duplicate order forms supplied by the Department to authorized hospital pharmacies for prescribing delta-9-THC to cancer chemotherapy patients and entitled "Research Order for delta-9-THC Medication".